| Recruiting | Transition to KPL-387 Monotherapy Dosing & Administration Study NCT07288216 | Kiniksa Pharmaceuticals International, plc | Phase 2 |
| Not Yet Recruiting | Pericardial Imaging Study NCT07245849 | Ottawa Heart Institute Research Corporation | Phase 3 |
| Not Yet Recruiting | EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases NCT07077304 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome NCT07468461 | Meyer Children's Hospital IRCCS | — |
| Recruiting | Phase 2/3 Study of KPL-387 in Recurrent Pericarditis NCT07010159 | Kiniksa Pharmaceuticals International, plc | Phase 2 / Phase 3 |
| Enrolling By Invitation | COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Usi NCT06763549 | Peerbridge Health, Inc | — |
| Active Not Recruiting | RUDRA Registry (Real-World Clinical Registry for Patients With Recurrent Pericarditis) NCT06517966 | Eurasian Association of Therapists | — |
| Not Yet Recruiting | Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR) NCT06411340 | King's College London | — |
| Recruiting | Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels NCT05925790 | ASST Fatebenefratelli Sacco | — |
| Not Yet Recruiting | Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children NCT05805930 | Istituto Giannina Gaslini | Phase 3 |
| Unknown | MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study NCT06103123 | Cardiology Research UBC | — |
| Recruiting | COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry NCT05046002 | Ottawa Heart Institute Research Corporation | — |
| Completed | Post-Ablation Pericarditis Reduction Study (PAPERS) NCT06731595 | St. Vincent Cardiovascular Research Institute | Phase 2 |
| Completed | Post-Ablation Pericarditis Reduction Study NCT04906720 | St. Vincent Cardiovascular Research Institute | Phase 2 |
| Completed | Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericardi NCT04692766 | R-Pharm International, LLC | Phase 2 / Phase 3 |
| Unknown | JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibi NCT04294771 | Groupe Hospitalier Pitie-Salpetriere | — |
| Unknown | Management of Pericarditis in Children. NCT03253315 | Assiut University | — |
| Unknown | A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa NCT03231449 | Cardiologie et Développement | — |
| Completed | Apolipoprotein CIII Reduction Via Colchicine NCT02083510 | Scripps Translational Science Institute | EARLY_Phase 1 |
| Completed | ACAM2000® Myopericarditis Registry NCT01395082 | Emergent BioSolutions | — |
| Unknown | Prognostic Biomarkers in Patients With Acute Pericarditis NCT02754713 | Hippocration General Hospital | — |
| Terminated | Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin NCT00946907 | University Hospital, Brest | Phase 4 |
| Completed | Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment. NCT00235079 | Azienda Sanitaria Locale 3, Torino | Phase 4 |
| Completed | Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences NCT00128453 | Azienda Sanitaria Locale 3, Torino | Phase 3 |
| Completed | Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode) NCT00128414 | Azienda Sanitaria Locale 3, Torino | Phase 3 |
| Unknown | Noise, a Risk for Heart in Airplane Pilots NCT01063582 | Universidad Politecnica de Madrid | — |
| Active Not Recruiting | Inflammatory Cardiomyopathy Bern Registry NCT04774549 | Insel Gruppe AG, University Hospital Bern | — |